AlphaTON bán mảng dược, tập trung hệ sinh thái Telegram
AlphaTON Capital Corp. announced that Immunova has exercised its option to acquire iOx Therapeutics, a wholly-owned subsidiary focused on cancer therapies. AlphaTON will receive 10% diluted equity of Immunova and potential payments exceeding $100 million. The company is restructuring to focus on investment strategies around blockchain ecosystems. ATON shares are currently trading at $0.47, down over 3% for the day and nearly 39% year-to-date.
TapChiBitcoin·02-19 00:22
